NK cells’ role in cancer therapy resistance unveiled

FHS
May 4, 2024
3:01 am

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system.

FDA denies approval for Astellas’ investigational gastric cancer drug – Pharmaceutical Technology

Share this article Astellas is working closely with the FDA and the third-party manufacturer to address the flagged deficiencies. Credits: JHVEPhoto/Shutterstock.com The US Food and

January 9, 2024

Just five minutes of activity a day could reduce blood pressure

Modest daily exercise, as little as five minutes, is linked to lower blood pressure, with significant benefits from longer activity durations.

November 11, 2024

Australian CAI unveils new facility for cancer therapy development

Through AFTRiC, the CAI has expanded what is already one of Australia’s most comprehensive suites of preclinical and clinical imaging research instruments. Credit: The University

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.